Avinger Inc financial data

Symbol
AVGR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
400 Chesapeake Drive, Redwood City, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 70.4 % -57.9%
Quick Ratio 26.1 % -33.8%
Debt-to-equity -459 % -168%
Return On Equity 422 %
Return On Assets -117 % -70.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.7 M shares -83.1%
Common Stock, Shares, Outstanding 1.59 M shares -81.6%
Entity Public Float 6.8 M USD -22.7%
Common Stock, Value, Issued 2 K USD -77.8%
Weighted Average Number of Shares Outstanding, Basic 1.48 M shares +170%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 5.91 M USD +7.37%
Research and Development Expense 4.25 M USD -9.16%
Operating Income (Loss) -17.5 M USD -12.5%
Net Income (Loss) Attributable to Parent -19.2 M USD -12.1%
Earnings Per Share, Basic -15.1 USD/shares +79.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.17 M USD -30.8%
Accounts Receivable, after Allowance for Credit Loss, Current 1.38 M USD +36.1%
Inventory, Net 4.56 M USD -14.2%
Assets, Current 14.1 M USD -20.1%
Property, Plant and Equipment, Net 523 K USD -8.08%
Operating Lease, Right-of-Use Asset 1.99 M USD +3.27%
Other Assets, Noncurrent 225 K USD -24%
Assets 16.9 M USD -17.6%
Accounts Payable, Current 747 K USD +44.5%
Employee-related Liabilities, Current 2.52 M USD +4.86%
Accrued Liabilities, Current 822 K USD +13.4%
Liabilities, Current 20.1 M USD -2.88%
Operating Lease, Liability, Noncurrent 835 K USD +3.34%
Other Liabilities, Noncurrent 15 K USD -97%
Liabilities 20.9 M USD -4.77%
Retained Earnings (Accumulated Deficit) -426 M USD -4.72%
Stockholders' Equity Attributable to Parent -4.05 M USD -172%
Liabilities and Equity 16.9 M USD -17.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.73 M USD -12.4%
Net Cash Provided by (Used in) Financing Activities 6.63 M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 1.59 M shares -81.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.9 M USD
Deferred Tax Assets, Valuation Allowance 99.4 M USD +3.51%
Deferred Tax Assets, Gross 99.6 M USD +3.19%
Operating Lease, Liability 1.99 M USD +3.27%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 2.1 M USD +2.89%
Property, Plant and Equipment, Gross 4.59 M USD -1.37%
Operating Lease, Liability, Current 1.16 M USD +3.21%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17 M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 934 K USD -17.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 109 K USD -3.54%
Deferred Tax Assets, Operating Loss Carryforwards 87.6 M USD +2.36%
Preferred Stock, Shares Issued 19.2 K shares -68.5%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 2.68 M USD +3.8%
Preferred Stock, Shares Outstanding 19.2 K shares -68.5%
Depreciation, Depletion and Amortization 83 K USD +15.3%
Deferred Tax Assets, Net of Valuation Allowance 278 K USD -50.4%
Share-based Payment Arrangement, Expense 1.79 M USD +460%
Interest Expense 1.74 M USD +7.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%